Schneider Capital Management Lifted Insys Therapeutics (INSY) Stake; PARKS AMERICA (PRKA) Shorts Increased By 272.73%

February 14, 2018 - By Ellis Scott

PARKS AMERICA INCORPORATED (OTCMKTS:PRKA) had an increase of 272.73% in short interest. PRKA’s SI was 4,100 shares in February as released by FINRA. Its up 272.73% from 1,100 shares previously. The stock decreased 2.32% or $0.0051 during the last trading session, reaching $0.2149. About 190 shares traded. Parks! America, Inc. (OTCMKTS:PRKA) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Schneider Capital Management Corp increased Insys Therapeutics Inc (INSY) stake by 51.62% reported in 2017Q3 SEC filing. Schneider Capital Management Corp acquired 61,927 shares as Insys Therapeutics Inc (INSY)’s stock rose 13.42%. The Schneider Capital Management Corp holds 181,900 shares with $1.62 million value, up from 119,973 last quarter. Insys Therapeutics Inc now has $611.46M valuation. The stock increased 3.86% or $0.31 during the last trading session, reaching $8.34. About 333,478 shares traded. INSYS Therapeutics, Inc. (NASDAQ:INSY) has declined 5.69% since February 14, 2017 and is downtrending. It has underperformed by 22.39% the S&P500.

Schneider Capital Management Corp decreased Halcon Resources Corporation stake by 2.29M shares to 1.78M valued at $12.10 million in 2017Q3. It also reduced Tronox Ltd. Cl A (NYSE:TROX) stake by 527,355 shares and now owns 72,904 shares. Consol Energy Inc (NYSE:CNX) was reduced too.

Among 6 analysts covering Insys Therapeutics (NASDAQ:INSY), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Insys Therapeutics had 22 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of INSYS Therapeutics, Inc. (NASDAQ:INSY) earned “Buy” rating by Jefferies on Monday, October 10. The firm has “Hold” rating given on Tuesday, August 4 by Oppenheimer. RBC Capital Markets maintained it with “Buy” rating and $14.0 target in Monday, October 9 report. The firm earned “Outperform” rating on Wednesday, December 21 by RBC Capital Markets. The rating was downgraded by Zacks to “Buy” on Friday, August 14. The firm has “Buy” rating by Jefferies given on Thursday, August 4. On Thursday, April 14 the stock rating was initiated by Janney Capital with “Buy”. Jefferies maintained INSYS Therapeutics, Inc. (NASDAQ:INSY) rating on Tuesday, April 12. Jefferies has “Buy” rating and $17 target. RBC Capital Markets maintained it with “Buy” rating and $1400 target in Thursday, August 3 report. The firm has “Buy” rating by RBC Capital Markets given on Thursday, June 1.

Investors sentiment increased to 1.25 in 2017 Q3. Its up 0.05, from 1.2 in 2017Q2. It increased, as 20 investors sold INSY shares while 20 reduced holdings. 19 funds opened positions while 31 raised stakes. 18.21 million shares or 3.74% more from 17.56 million shares in 2017Q2 were reported. Ahl Prtnrs Ltd Liability Partnership accumulated 15,622 shares. Perigon Wealth Lc accumulated 57 shares. Great West Life Assurance Can reported 0% of its portfolio in INSYS Therapeutics, Inc. (NASDAQ:INSY). Legal & General Gru Public Ltd Co holds 0% in INSYS Therapeutics, Inc. (NASDAQ:INSY) or 7,870 shares. Macroview Mgmt Limited Liability Corporation holds 100 shares or 0% of its portfolio. Nationwide Fund Advsr holds 0% of its portfolio in INSYS Therapeutics, Inc. (NASDAQ:INSY) for 13,506 shares. Northern Trust Corporation holds 0% of its portfolio in INSYS Therapeutics, Inc. (NASDAQ:INSY) for 313,211 shares. Meeder Asset stated it has 705 shares or 0% of all its holdings. Schwab Charles Invest Mngmt invested in 0% or 104,812 shares. Moreover, Jpmorgan Chase And Com has 0% invested in INSYS Therapeutics, Inc. (NASDAQ:INSY) for 57,554 shares. The Pennsylvania-based Schneider Cap Mngmt Corp has invested 0.29% in INSYS Therapeutics, Inc. (NASDAQ:INSY). Dimensional Fund Limited Partnership reported 0% stake. Zacks Invest Mngmt accumulated 12,525 shares. National Bank Of Montreal Can has 0% invested in INSYS Therapeutics, Inc. (NASDAQ:INSY). Orbimed Advsr Limited Liability reported 6.17 million shares.

Parks! America, Inc., through its subsidiaries, engages in acquiring, developing, and operating local and regional theme parks and attractions in the United States. The company has market cap of $16.06 million. It owns and operates two Wild Animal Safari theme parks located in Pine Mountain, Georgia; and Strafford, Missouri. It has a 14.33 P/E ratio. The firm was formerly known as Great American Family Parks, Inc. and changed its name to Parks! America, Inc. in June 2008.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>